Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT07219069
Eligibility Criteria:
Inclusion Criteria:
* Admission to the medical ICU
* Intubated on mechanical ventilation
* On sedation medication infusion
Exclusion Criteria:
* Patients with a history of chronic opioid use
* Patients with end-stage liver disease at ICU admission (i.e., International normalized ratio \>1.5 and not taking warfarin and/or a total serum bilirubin 1.5 times above normal limits)
* Pregnant patients
* Current prisoner
* Refractory shock: Mean arterial blood pressure below 65 millimeters of mercury(65mmHg) despite maximum doses of 3 pressors. Norepinephrine 70mcg/min; vasopressin 0.03 units/min; epinephrine 35mcg/min; dopamine 20mcg/kg/min and phenylephrine 350mcg/min
* Inability to complete the required time for follow-up
* Surgical admission diagnosis
* Patients with skin conditions precluding BIS monitor sensor adherence
* Patients on neuromuscular blockade infusion or benzodiazepine infusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07219069
Study Brief:
Protocol Section:
NCT07219069